 |
 |
|
 |
 |
News from SGC
Posted on Tuesday 10th of March 2015
Open-access research into drug discovery has arrived in South America, with a ground-breaking collaboration between leading scientists in North America, Europe and Brazil to provide completely free and open research results to the world.
A $4.3-million (USD) grant from the São Paulo Research Foundation (FAPESP) plus an in-kind contribution of US$ 1.9 million by The University of Campinas (UNICAMP), totalling US$ 6,2 million, will establish Brazil’s first open-access research facility, the Protein Kinase Chemical Biology Centre at the UNICAMP in Brazil.
Posted on Friday 27th of February 2015
Fibrodysplasia ossificans progressiva (FOP) is one of the rarest and most disabling genetic conditions known. The University of Oxford is one of the few places in the world where this disease is being researched, with support from donations.
Posted on Thursday 26th of February 2015
GMEC is pleased to announce the signing of the first collaborative research projects to be launched under theGMEC/Pfizer Rare Diseases agreement which was announced in 2014.
The University of Oxford and Pfizer have agreed three funded research projects in the fields of haematology and neuromuscular disorders. For additional information click here to see the announcement by University of Oxford.
Posted on Wednesday 25th of February 2015
A new Drug Discovery Institute in Oxford focusing on finding new medicines for Azheimer’s is being funded by Alzheimer’s Research UK. The SGC will play a major role in this Institute, providing our expertise in protein production, protein crystallography and medicinal chemistry.
Read more:
Posted on Wednesday 4th of February 2015
This morning at MaRS Discovery District, Merck confirmed its commitment to research and innovation with a $7.5 million contribution to the Structural Genomics Consortium Toronto. (From left to right) Dr. Ronan O'Hagan, Dr. Aled Edwards, The Honourable Reza Moridi, Mr. Chirfi Guindo and Ms. Jennifer Chan. (CNW Group/Merck)
Posted on Monday 15th of December 2014
TORONTO, ON (December 9, 2014) — Dr. Aled Edwards, co-founder and CEO of Structural Genomics Consortium (SGC), has been elected a Senior Ashoka Fellow.
Posted on Monday 24th of November 2014
$2 million grant from the Bill & Melinda Gates Foundation furthers existing research on malaria and TB
Toronto, ON --Almost $2 million is being invested by the Bill & Melinda Gates Foundation to help fight major parasitic diseases of the developing world.
Posted on Tuesday 11th of November 2014
As part of the International Year of Crystallography, the NDM at the University of Oxford has produced a four part documentary explaining how the field of structural biology has developed over the past 100 years, Oxford’s involvement in that development, and where we go from here.
Posted on Wednesday 29th of October 2014
The SGC-CHDI open access patent-free partnership for Huntington’s disease research has been selected as a featured Innovator to present on November 17th at the 6th annual Partnering for Cures meeting in New York City, NY. The conference will bring together nearly 1,000 medical research leaders, investors and decision-makers to forge the collaborations needed to speed and improve outcomes-driven R&D.
Posted on Tuesday 28th of October 2014
2014 is the International Year of Crystallography and to celebrate this event NDM has produced a series of short films.
‘Revolutionary Biology’: Revolutionary Biology shows how the field of structural biology has developed over the past 100 years, Oxford’s involvement in that development, and where we go from here.
Pages
